Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC).
- Authors:
- RL Coleman, EM Swisher, AM Oza, CL Scott, H Giordano, KK Lin, GE Konecny, A Tinker, DM O'Malley, RS Kristeleit, L Ma, KM Bell-McGuinn, JD Brenton, JM Cragun, A Oaknin, IL Ray-Coquard, SH Kaufmann, S Goble, L Maloney, IA McNeish
- Journal:
- Journal of Clinical Oncology
- Citation info:
- 34(15_suppl):5540-5540
- Publication date:
- 20th May 2016
- Full text
- DOI